Cargando…

The Changing Face of Spondyloarthropathies Under TNF α Blockade

OBJECTIVES: Tumor necrosis factor alpha (TNF-α ) therapy has been implicated in the development of autoimmune diseases. Our aim was to describe three patients with spondyloarthropathies who responded to infliximab, a chimeric monoclonal antibody specific for TNF-α but developed new symptoms of spond...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkayam, Ori, Litinsky, Irena, Levartovsky, David, Caspi, Dan
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588090/
https://www.ncbi.nlm.nih.gov/pubmed/19088872
http://dx.doi.org/10.2174/1874312900802010053

Ejemplares similares